Identification of genetically driven Therapeutic Targets for Alzheimer’s disease
Alison M Goate, Edoardo Marcora, Carlos Cruchaga · 2025
Read Identification of genetically driven Therapeutic Targets for Alzheimer’s disease by Alison M Goate, Edoardo Marcora, Carlos Cruchaga (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709954.txt.
Description
Alison M Goate, Edoardo Marcora, and Carlos Cruchaga review a 2025 conference abstract on gene-driven drug targets for Alzheimer's disease. Drugs aimed at targets backed by human genetics reach approval at more than twice the usual rate. A national sequencing project has now found over one hundred risk regions, and follow-up work has named likely causal genes for many of them.
Gene and cell studies point hard at myeloid cells, including microglia, as risk carriers. One cleanup process, efferocytosis, stands out as a risk hub, and TREM2 signaling is implicated by several genes. Therapies aimed at TREM2, APOE, and related targets are in development.
Catalog record
| CREATOR | Alison M Goate, Edoardo Marcora, Carlos Cruchaga |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |